Private equity backs investor rights in Asia

Private equity firms in Asia have become unlikely champions for investor rights in the region.

Spurred by a string of soured deals and growing confidence in the legal process for creditors in Asia, funds are increasingly going after companies that haven't met financial obligations and pushing for a legal solution - such as liquidation.

One recent example is China Taizinai, a Chinese yogurt drinks maker now in liquidation which has a long line of creditors starting with UK-based private equity firm Actis. Other deals include China Sun Bio-Chem Technology Group Company, a Chinese corn starch producer also in liquidation, and Bio-Treat Technology, a Chinese wastewater treatment company that defaulted on its repayment of US$206m in convertible bonds. Convertible bondholders, including Morley Fund Management, Merrill Lynch and Citigroup, ended up taking a steep haircut.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump